H W Pyun1, D H Lee, H M Yoo, J H Lee, C G Choi, S J Kim, D C Suh. 1. Department of Radiology and Research Institute of Radiology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.
Abstract
BACKGROUND AND PURPOSE: Placement of a covered stent to control carotid blowout (CB) in malignant tumors of the head and neck has been reported to be an effective treatment. However, it is not uncommon to encounter recurrent hemorrhage. The purpose of this study was to evaluate the follow-up results of patients treated with covered stents. MATERIALS AND METHODS: We retrospectively reviewed the results of 7 consecutive patients who underwent placement of a covered stent to control CB. Most of them had poor wound healing because of previous irradiation, surgery, or both. The initial procedures were successful in all patients. Their clinical course was reviewed for rebleeding, additional endovascular treatments in recurrent cases, and outcomes. RESULTS: Recurrence developed in 6 of 7 patients. The interval between the first procedure and the hemorrhagic event was from 3 to 44 days. In 6 patients who had a recurrent CB, 4 had rebleeding from the previous site of the stent, whereas 2 other patients experienced recurrent bleeding in a different area from the site of the stent. Additional endovascular treatments were carried out in all affected patients by another insertion of a covered stent (n = 3), coil embolization (n = 2), or insertion of a covered stent followed by permanent arterial occlusion (n = 1). CONCLUSION: Placement of a covered stent in patients with head and neck cancer who sustain CB showed frequent rebleeding despite favorable initial rescue results. Recurrent CB at the previous stent site developed frequently in patients with uncontrolled wound infection. Concomitant or short-interval arterial trapping should be considered selectively in those conditions.
BACKGROUND AND PURPOSE: Placement of a covered stent to control carotid blowout (CB) in malignant tumors of the head and neck has been reported to be an effective treatment. However, it is not uncommon to encounter recurrent hemorrhage. The purpose of this study was to evaluate the follow-up results of patients treated with covered stents. MATERIALS AND METHODS: We retrospectively reviewed the results of 7 consecutive patients who underwent placement of a covered stent to control CB. Most of them had poor wound healing because of previous irradiation, surgery, or both. The initial procedures were successful in all patients. Their clinical course was reviewed for rebleeding, additional endovascular treatments in recurrent cases, and outcomes. RESULTS: Recurrence developed in 6 of 7 patients. The interval between the first procedure and the hemorrhagic event was from 3 to 44 days. In 6 patients who had a recurrent CB, 4 had rebleeding from the previous site of the stent, whereas 2 other patients experienced recurrent bleeding in a different area from the site of the stent. Additional endovascular treatments were carried out in all affected patients by another insertion of a covered stent (n = 3), coil embolization (n = 2), or insertion of a covered stent followed by permanent arterial occlusion (n = 1). CONCLUSION: Placement of a covered stent in patients with head and neck cancer who sustain CB showed frequent rebleeding despite favorable initial rescue results. Recurrent CB at the previous stent site developed frequently in patients with uncontrolled wound infection. Concomitant or short-interval arterial trapping should be considered selectively in those conditions.
Authors: Tao Upile; Stefanos Triaridis; Paul Kirkland; Daniel Archer; Adam Searle; Colm Irving; Peter Rhys Evans Journal: Eur Arch Otorhinolaryngol Date: 2005-03-17 Impact factor: 2.503
Authors: J C Chaloupka; T C Roth; C M Putman; S Mitra; D A Ross; R A Lowlicht; C T Sasaki Journal: AJNR Am J Neuroradiol Date: 1999 Jun-Jul Impact factor: 3.825
Authors: Walter S Lesley; John C Chaloupka; John B Weigele; Sundeep Mangla; Mohammad A Dogar Journal: AJNR Am J Neuroradiol Date: 2003-05 Impact factor: 3.825
Authors: E Pampana; R Gandini; M Stefanini; S Fabiano; A Chiaravalloti; D Morosetti; S Spano; G Simonetti Journal: Interv Neuroradiol Date: 2011-12-16 Impact factor: 1.610
Authors: André Beer-Furlan; Ashley Heilingoetter; Christopher Rayle; Thomas O'Toole; Thomas J Nielsen; Richard Webster Crowley; Samer Al-Khudari Journal: J Neurol Surg B Skull Base Date: 2020-10-12